ARCHIVES

NCABP “Anyone With Same Facts Would Have Come To Same Conclusion

This article is from The Cancer Letter archive.

Vol. 20 No. 41 | October 28, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Funding opportunities listed.

September 24, 2004

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010